RecruitingPhase 3NCT06376981

Hyaluronic Acid in Shoulder Tendinopathy

Benefit of a Subacromial Injection Combining Corticosteroid and Hyaluronic Acid Versus Corticosteroid Alone in Supraspinatus Tendinopathy

Sponsor

Centre Hospitalier Departemental Vendee

Enrollment

132 participants

Start Date

Sep 19, 2024

Study Type

INTERVENTIONAL

Conditions

Shoulder Tendinitis

Summary

Multicentric, randomised study to compare the effectiveness on activity pain at 3 months of corticosteroid injection associated with hyaluronic acid with corticosteroids injection alone in patients with tendinopathy of the supraspinatus with clinical reevaluation at one, three and six months.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Corticosteroid injection, a drug called Hyaluronic acid injection, and others for people with shoulder tendinitis. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHyaluronic acid injection

An injection of 2 ml of Acid hyaluronic

DRUGCorticosteroid injection

An injection of 1 ml of corticosteroids

DRUGPlacebo injection

An injection of 2 ml of placebo (physiological serum)

Locations(2)

CHD Vendée

La Roche-sur-Yon, France

CHU Nantes

Nantes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06376981

Related Trials

Electroacupuncture and Cupping for Shoulder Tendinitis

NCT075457852 locations

Subacromial Impingement Syndrome Functional Tests Correlation With Ultrasound Parameters

NCT063844301 location